Federated Hermes, Inc. Connect Biopharma Holdings LTD Transaction History

Federated Hermes, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$18.12 - $28.5 $217,440 - $342,000	-12,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$14.16 - $19.53 $396,480 - $546,840	-28,000 Reduced 70.0%	12,000 $234,000
Q1 2021 May 13, 2021	BUY	$15.9 - $18.61 $636,000 - $744,400	40,000 New	40,000 $740,000

3.05M

Ticker CNTB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,015,800
Market Cap $59.4M
Description
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.